SCHEMBL30158119

SCHEMBL30158119

O=C(OC1CCCOC12CCCO2)c1cccc(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 2/20 0.49
▸ CYP1A2 P05177 1/20 0.45
▸ GAA P10253 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ GRM5 P41594 1/20 0.39
▸ LMNA P02545 1/20 0.38
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ ESR2 Q92731 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30158054 0.96 KMT2A (0.48) KMT2ACYP1A2GAACYP2C9HPGD
SCHEMBL30158275 0.88 KMT2A (0.34) KMT2ACYP1A2GAACYP2C9HPGD
SCHEMBL30158277 0.85 HPGD (0.45) KMT2ACYP2C9HPGDCYP2C19MEN1
SCHEMBL30158279 0.85 RAB9A (0.38) KMT2ANPC1RAB9AMEN1MAPK1
SCHEMBL30158161 0.85 KMT2A (0.43) KMT2AGAAHPGDMEN1
SCHEMBL30158191 0.84 ALDH1A1 (0.51) GAACYP2C9HPGDCYP2C19NPC1
SCHEMBL30157975 0.82 HPGD (0.44) KMT2ACYP2C9HPGDCYP2C19MEN1
SCHEMBL30158112 0.81 DHODH (0.34) KMT2ACYP1A2GAACYP2C9HPGD
SCHEMBL30158212 0.81 RAB9A (0.41) KMT2ANPC1RAB9AMEN1CES2
SCHEMBL30158079 0.81 ALDH1A1 (0.50) GAAHPGDNPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023277630-A1 GALACTOSIDE DERIVATIVE AS GALECTIN-3 INHIBITOR 주식회사 티움바이오 2023-01-05 — — WO disclosed
Send feedback